The role of the CX3CL1/CX3CR1 axis as potential inflammatory biomarkers in subjects with periodontitis and rheumatoid arthritis: A systematic review

被引:3
|
作者
Alarcon-Sanchez, Mario A. [1 ]
Becerra-Ruiz, Julieta S. [2 ]
Guerrero-Velazquez, Celia [3 ]
Mosaddad, Seyed A. [4 ,5 ,8 ]
Heboyan, Artak [4 ,6 ,7 ,8 ,9 ,10 ]
机构
[1] Autonomous Univ Guerrero, Fac Chem Biol Sci, Biomed Sci, Guerrero, Mexico
[2] Univ Guadalajara, Univ Ctr Los Altos, Inst Res Biosci, Guadalajara, Mexico
[3] Univ Guadalajara, Southern Univ Ctr, Res Ctr Mol Biol Chron Dis, Guadalajara, Mexico
[4] Saveetha Univ, Dept Res Analyt, Saveetha Dent Coll & Hosp, Saveetha Inst Med & Tech Sci, Chennai, India
[5] Shiraz Univ Med Sci, Student Res Comm, Sch Dent, Shiraz, Iran
[6] Yerevan State Med Univ, Fac Stomatol, Dept Prosthodont, Yerevan, Armenia
[7] Univ Tehran Med Sci, Dept Prosthodont, Tehran, Iran
[8] Saveetha Univ, Dept Res Analyt, Saveetha Dent Coll & Hosp, Saveetha Inst Med & Tech Sci, Chennai 600077, India
[9] Yerevan State Med Univ, Fac Stomatol, Dept Prosthodont, Str Koryun 2, Yerevan 0025, Armenia
[10] Univ Tehran Med Sci, Sch Dent, Dept Prosthodont, North Karegar St, Tehran, Iran
关键词
biomarkers of inflammation; chemokines; CX3CL1; CX3CR1; fractalkine; periodontitis; rheumatoid arthritis; FRACTALKINE RECEPTOR CX(3)CR1; CHEMOKINE; CX3CL1; CLASSIFICATION; EXPRESSION; MIGRATION;
D O I
10.1002/iid3.1181
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: This systematic review aimed to investigate the role of the C-X3-C motif ligand 1/chemokine receptor 1 C-X3-C motif (CX3CL1/CX3CR1) axis in the pathogenesis of periodontitis. Furthermore, as a secondary objective, we determine whether the CX3CL1/CX3CR1 axis could be considered complementary to clinical parameters to distinguish between periodontitis and rheumatoid arthritis (RA) and/or systemically healthy subjects. Methods: The protocol used for this review was registered in OSF (10.17605/OSF.IO/KU8FJ). This study was designed following Preferred Reporting Items for Systematic Review and Meta-Analysis guidelines. Records were identified using different search engines (PubMed/MEDLINE, Scopus, Science Direct, and Web of Science) from August 10, 2006, to September 15, 2023. The observational studies on human subjects diagnosed with periodontitis and RA and/or systemically healthy were selected to analyze CX3CL1 and CX3CR1 biomarkers. The methodological validity of the selected articles was assessed using NIH. Results: Six articles were included. Biological samples (gingival crevicular fluid [GCF], saliva, gingival tissue biopsies, serum) from 379 subjects (n = 275 exposure group and n = 104 control group) were analyzed. Higher CX3CL1 and CX3CR1 chemokine levels were found in subjects with periodontitis and RA compared with periodontal and systemically healthy subjects. Conclusion: Very few studies highlight the role of the CX3CL1/CX3CR1 axis in the pathogenesis of periodontitis; however, increased levels of these chemokines are observed in different biological samples (GCF, gingival tissue, saliva, and serum) from subjects with periodontitis and RA compared with their healthy controls. Future studies should focus on long-term follow-up of subjects and monitoring changes in cytokine levels before and after periodontal therapy to deduce an appropriate interval in health and disease conditions.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] Role of chemokine CX3CL1 in progression of multiple myeloma via CX3CR1 in bone microenvironments
    Wada, Akinori
    Ito, Aya
    Iitsuka, Hirofumi
    Tsuneyama, Koichi
    Miyazono, Takayoshi
    Murakami, Jun
    Shibahara, Naotoshi
    Sakurai, Hiroaki
    Saiki, Ikuo
    Nakayama, Takashi
    Yoshie, Osamu
    Koizumi, Keiichi
    Sugiyama, Toshiro
    ONCOLOGY REPORTS, 2015, 33 (06) : 2935 - 2939
  • [42] Functional role of fractalkine (CX3CL1) in rheumatoid arthritis.
    Blaschke, S
    Koziolek, M
    Schwarz, A
    Benöhr, P
    Middel, P
    Schwarz, G
    Hummel, KM
    Müller, GA
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S278 - S278
  • [43] Early activation of the cardiac CX3CL1/CX3CR1 axis delays β-adrenergic-induced heart failure
    Flamant, M.
    Mougenot, N.
    Balse, E.
    Le Fevre, L.
    Atassi, F.
    Gautier, E. L.
    Le Goff, W.
    Keck, M.
    Nadaud, S.
    Combadiere, C.
    Boissonnas, A.
    Pavoine, C.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [44] Hydrogen Sulfide Inhibits the Development of Atherosclerosis with Suppressing CX3CR1 and CX3CL1 Expression
    Zhang, Huili
    Guo, Changfa
    Wu, Duojiao
    Zhang, Alian
    Gu, Ting
    Wang, Liansheng
    Wang, Changqian
    PLOS ONE, 2012, 7 (07):
  • [45] Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis
    Hasegawa, M
    Sato, S
    Echigo, T
    Hamaguchi, Y
    Yasui, M
    Takehara, K
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (01) : 21 - 28
  • [46] Influence of aspirin on the CX3CL1/CX3CR1 signaling pathway in acute pulmonary embolism
    Zhang, Zhirong
    Yang, Weiji
    Ying, Rongbiao
    Shi, Ying
    Jiang, Huifang
    Cai, Danli
    Kuang, Jing
    Yang, Ruhui
    Wang, Lingcong
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2017, 39 (06) : 1580 - 1588
  • [47] Expression of CX3CL1 and CX3CR1 in human asthmatic lung in relation to cell survival
    Cunoosamy, Danes
    Zhou, Xiao-Hong
    Rehnberg, Maria
    Svensson, Karin
    Sandberg, Kristian
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [48] Early activation of the cardiac CX3CL1/CX3CR1 axis delays β-adrenergic-induced heart failure
    M. Flamant
    N. Mougenot
    E. Balse
    L. Le Fèvre
    F. Atassi
    E. L. Gautier
    W. Le Goff
    M. Keck
    S. Nadaud
    C. Combadière
    A. Boissonnas
    C. Pavoine
    Scientific Reports, 11
  • [49] Association of CX3CL1 and CX3CR1 Expression with Liver Fibrosis in a Mouse Model of Schistosomiasis
    Zhang, Pan
    Wang, Bao-ju
    Wang, Jun-zhong
    Xie, Xu-mao
    Tong, Qiao-xiao
    CURRENT MEDICAL SCIENCE, 2020, 40 (06): : 1121 - 1127
  • [50] Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in periodontal diseased tissue
    Hosokawa, Y
    Nakanishi, T
    Yamaguchi, D
    Nakae, H
    Matsuo, T
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2005, 139 (03): : 506 - 512